Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Amendment history:
  • Correction (December 1992)

Research Article Free access | 10.1172/JCI115812

Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.

S J Rosenfeld, K Yoshimoto, S Kajigaya, S Anderson, N S Young, A Field, P Warrener, G Bansal, and M S Collett

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Rosenfeld, S. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Yoshimoto, K. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Kajigaya, S. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Anderson, S. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Young, N. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Field, A. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Warrener, P. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Bansal, G. in: PubMed | Google Scholar

Cell Biology Section, National Heart, Lung and Blood Institute, Bethesda, Maryland 20817.

Find articles by Collett, M. in: PubMed | Google Scholar

Published June 1, 1992 - More info

Published in Volume 89, Issue 6 on June 1, 1992
J Clin Invest. 1992;89(6):2023–2029. https://doi.org/10.1172/JCI115812.
© 1992 The American Society for Clinical Investigation
Published June 1, 1992 - Version history
View PDF
Abstract

Capsids of the B19 parvovirus are composed of major (VP2; 58 kD) and minor (VP1; 83 kD) structural proteins. These proteins are identical except for a unique 226 amino acid region at the amino terminus of VP1. Previous immunization studies with recombinant empty capsids have demonstrated that the presence of VP1 was required to elicit virus-neutralizing antibody activity. However, to date, neutralizing epitopes have been identified only on VP2. Crystallographic studies of a related parvovirus (canine parvovirus) suggested the unique amino-terminal portion of VP1 assumed an internal position within the viral capsid. To determine the position of VP1 in both empty capsids and virions, we expressed a fusion protein containing the unique region of VP1. Antisera raised to this protein recognized recombinant empty capsids containing VP1 and VP2, but not those containing VP2 alone, in an enzyme-linked immunosorbent assay. The antisera immunoprecipitated both recombinant empty capsids and human plasma-derived virions, and agglutinated the latter as shown by immune electron microscopy. The sera contained potent neutralizing activity for virus infectivity in vitro. These data indicate that a portion of the amino terminus of VP1 is located on the virion surface, and that this region contains intrinsic neutralizing determinants. The external location of the VP1-specific tail may provide a site for engineered heterologous epitope presentation in novel recombinant vaccines.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2023
page 2023
icon of scanned page 2024
page 2024
icon of scanned page 2025
page 2025
icon of scanned page 2026
page 2026
icon of scanned page 2027
page 2027
icon of scanned page 2028
page 2028
icon of scanned page 2029
page 2029
Version history
  • Version 1 (June 1, 1992): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts